DaVita Pre-Paid Expenses 2010-2024 | DVA

DaVita pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • DaVita pre-paid expenses for the quarter ending September 30, 2024 were $0.097B, a 6.45% increase year-over-year.
  • DaVita pre-paid expenses for 2023 were $0.103B, a 30.2% increase from 2022.
  • DaVita pre-paid expenses for 2022 were $0.079B, a 8.72% increase from 2021.
  • DaVita pre-paid expenses for 2021 were $0.073B, a 5.07% decline from 2020.
DaVita Annual Pre-Paid Expenses
(Millions of US $)
2023 $103
2022 $79
2021 $73
2020 $76
2019 $67
2018 $112
2017 $112
2016 $100
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
DaVita Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $97
2024-06-30 $83
2024-03-31 $105
2023-12-31 $103
2023-09-30 $91
2023-06-30 $90
2023-03-31 $89
2022-12-31 $79
2022-09-30 $66
2022-06-30 $64
2022-03-31 $79
2021-12-31 $73
2021-09-30 $69
2021-06-30 $69
2021-03-31 $74
2020-12-31 $76
2020-09-30 $59
2020-06-30 $63
2020-03-31 $60
2019-12-31 $67
2019-09-30 $51
2019-06-30 $55
2019-03-31 $65
2018-12-31 $112
2018-09-30 $89
2018-06-30 $97
2018-03-31 $106
2017-12-31 $112
2017-09-30
2017-06-30
2017-03-31
2016-12-31 $100
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.272B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00